vimarsana.com

Page 15 - Formulation Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Berkshire Sterile to offer formulation, lyophilization, and

Lee, MA, Feb. 09, 2022 (GLOBE NEWSWIRE) Berkshire Sterile Manufacturing (BSM), a sterile filling contract manufacturer located in Lee, MA, has.

Xufeng sunAndrea wagnerShawn kinneySterile manufacturingTechnology transferBerkshire sterile manufacturingMethod developmentFormulation developmentYophilization developmentBerkshire sterile

APNAR Pharma Acquires New Jersey Based Aurex Laboratories with US FDA Approved Finished Dosage Capabilities Expanding its Global Footprint

We develop, manufacture, package, sell, market, and distribute generic pharmaceuticals and OTCs. APNAR has RD and manufacturing facilities in East Windsor, NJ, United States and Gavasad, Gujarat, India.www.apnarpharma.com PWR PWR

East windsorUnited statesNew jerseyDharmesh patelSanjay bhargavNailesh bhattGlobal companyFormulation developmentState of the art manufacturing facilityAlso knownMedicine chestSoft gelsLiquid drugsControlled substanceFully integrated global companyBusiness model allows

Immorna Biotherapeutics Expands Its R&D Footprint in RTP, NC and Appoints Key Senior Scientific Leaders

RALEIGH, N.C., Jan. 31, 2022 /PRNewswire/ Immorna Biotherapeutics, Inc, an immune-oncology drug and viral vaccine development company with both.

Lan fengImmorna biotherapeuticsSucampo pharmaZihao wangJeffrey careyMarcin bugnoJeffrey ulmerMedlmmune astrazenecaNgocdiep leBlas ndasHead of regulatory affairs at neoimmunetechStanford university school of medicineUniversity of north carolinaJagiellonian universityUs vaccine discovery groupGlobal head of external research

Immorna Biotherapeutics Expands Its R&D Footprint in RTP, NC and Appoints Key Senior Scientific Leaders

/PRNewswire/ Immorna Biotherapeutics, Inc, an immune-oncology drug and viral vaccine development company with both proprietary self-replicating mRNA and.

Lan fengImmorna biotherapeuticsSucampo pharmaMarcin bugnoJeffrey careyJeffrey ulmerMedlmmune astrazenecaNgocdiep leBlas ndasHead of regulatory affairs at neoimmunetechStanford university school of medicineUniversity of north carolinaJagiellonian universityUs vaccine discovery groupGlobal head of external researchMcgill university

Immorna Biotherapeutics Expands Its R&D Footprint in RTP, NC and Appoints Key Senior Scientific Leaders

/PRNewswire/ Immorna Biotherapeutics, Inc, an immune-oncology drug and viral vaccine development company with both proprietary self-replicating mRNA and.

Lan fengImmorna biotherapeuticsSucampo pharmaMarcin bugnoJeffrey careyJeffrey ulmerMedlmmune astrazenecaNgocdiep leBlas ndasHead of regulatory affairs at neoimmunetechStanford university school of medicineUniversity of north carolinaJagiellonian universityUs vaccine discovery groupGlobal head of external researchMcgill university

vimarsana © 2020. All Rights Reserved.